After initial training as a chemical engineer, I began to work with in vivo imaging techniques on the themes of neurodegeneration and neuroinflammation, using Positron Emission Tomography (PET) during my PhD and then Magnetic Resonance Imaging (MRI) during my post-doctorate. Since my appointment to the Lyon Neuroscience Research Center at the end of 2012, I have been studying pathological protein aggregates involved in neurodegenerative diseases, as well as demyelinating damage to cerebral white matter, using animal models of neurological diseases, using PET, MRI and, more recently, X-ray imaging.